vs
Side-by-side financial comparison of Massimo Group (MAMO) and Spero Therapeutics, Inc. (SPRO). Click either name above to swap in a different company.
Massimo Group is the larger business by last-quarter revenue ($21.0M vs $12.6M, roughly 1.7× Spero Therapeutics, Inc.). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs 9.5%, a 241.2% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs 15.7%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs -16.5%).
Massimo Dutti, S.A. is a Spanish premium clothing retailer specializing in cashmere and wool products, established in 1985 and owned by Spanish multinational company Inditex, the parent company of Zara, Pull&Bear, and other brands.
MAMO vs SPRO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.0M | $12.6M |
| Net Profit | $2.0M | $31.5M |
| Gross Margin | 41.5% | — |
| Operating Margin | 13.1% | — |
| Net Margin | 9.5% | 250.7% |
| Revenue YoY | 15.7% | 24080.8% |
| Net Profit YoY | 215.0% | 250.9% |
| EPS (diluted) | $0.05 | $0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $21.0M | $12.6M | ||
| Q3 25 | $17.0M | $0 | ||
| Q2 25 | $18.9M | $0 | ||
| Q1 25 | $14.9M | $12.0K | ||
| Q4 24 | $18.2M | $52.0K | ||
| Q3 24 | $25.6M | $65.0K | ||
| Q2 24 | $35.4M | $114.0K | ||
| Q1 24 | $30.2M | $140.0K |
| Q4 25 | $2.0M | $31.5M | ||
| Q3 25 | $1.5M | $-7.4M | ||
| Q2 25 | $77.7K | $-1.7M | ||
| Q1 25 | $-2.1M | $-13.9M | ||
| Q4 24 | $-1.7M | — | ||
| Q3 24 | $-2.5M | $-17.1M | ||
| Q2 24 | $2.8M | $-17.9M | ||
| Q1 24 | $3.2M | $-12.7M |
| Q4 25 | 41.5% | — | ||
| Q3 25 | 42.0% | — | ||
| Q2 25 | 36.3% | — | ||
| Q1 25 | 28.4% | — | ||
| Q4 24 | 19.6% | — | ||
| Q3 24 | 27.2% | — | ||
| Q2 24 | 32.5% | — | ||
| Q1 24 | 34.7% | — |
| Q4 25 | 13.1% | — | ||
| Q3 25 | 10.5% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | -18.2% | -122758.3% | ||
| Q4 24 | -15.4% | — | ||
| Q3 24 | 1.2% | -28604.6% | ||
| Q2 24 | 10.1% | -16720.2% | ||
| Q1 24 | 13.2% | -9987.1% |
| Q4 25 | 9.5% | 250.7% | ||
| Q3 25 | 9.0% | — | ||
| Q2 25 | 0.4% | — | ||
| Q1 25 | -14.0% | -115550.0% | ||
| Q4 24 | -9.5% | — | ||
| Q3 24 | -9.8% | -26380.0% | ||
| Q2 24 | 8.0% | -15668.4% | ||
| Q1 24 | 10.6% | -9049.3% |
| Q4 25 | $0.05 | $0.56 | ||
| Q3 25 | $0.04 | $-0.13 | ||
| Q2 25 | $0.00 | $-0.03 | ||
| Q1 25 | $-0.05 | $-0.25 | ||
| Q4 24 | $-0.05 | — | ||
| Q3 24 | $-0.06 | $-0.32 | ||
| Q2 24 | $0.07 | $-0.33 | ||
| Q1 24 | $0.08 | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.8M | $40.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $23.7M | $59.0M |
| Total Assets | $51.4M | $68.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.8M | $40.3M | ||
| Q3 25 | $2.6M | $48.6M | ||
| Q2 25 | — | $31.2M | ||
| Q1 25 | $3.0M | $48.9M | ||
| Q4 24 | $10.2M | $52.9M | ||
| Q3 24 | — | $76.3M | ||
| Q2 24 | — | $63.5M | ||
| Q1 24 | — | $82.3M |
| Q4 25 | $23.7M | $59.0M | ||
| Q3 25 | $21.7M | $26.5M | ||
| Q2 25 | $20.2M | $32.8M | ||
| Q1 25 | $19.9M | $33.8M | ||
| Q4 24 | $21.7M | $46.1M | ||
| Q3 24 | $22.5M | $65.5M | ||
| Q2 24 | $24.7M | $80.5M | ||
| Q1 24 | $18.1M | $96.2M |
| Q4 25 | $51.4M | $68.9M | ||
| Q3 25 | $44.4M | $54.2M | ||
| Q2 25 | $45.9M | $62.1M | ||
| Q1 25 | $46.4M | $77.7M | ||
| Q4 24 | $54.9M | $110.5M | ||
| Q3 24 | $57.1M | $135.2M | ||
| Q2 24 | $49.9M | $149.9M | ||
| Q1 24 | $47.3M | $167.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.0M | $-8.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 2.01× | -0.26× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.0M | $-8.4M | ||
| Q3 25 | $633.2K | $17.4M | ||
| Q2 25 | $-1.4M | $-17.7M | ||
| Q1 25 | $-3.3M | $-4.0M | ||
| Q4 24 | $9.1M | $-23.4M | ||
| Q3 24 | $4.7M | $12.8M | ||
| Q2 24 | $-6.5M | $-18.7M | ||
| Q1 24 | $-637.0K | $5.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $9.0M | — | ||
| Q3 24 | $4.6M | — | ||
| Q2 24 | $-6.7M | — | ||
| Q1 24 | $-741.4K | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 49.7% | — | ||
| Q3 24 | 18.1% | — | ||
| Q2 24 | -19.0% | — | ||
| Q1 24 | -2.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | 0.3% | — |
| Q4 25 | 2.01× | -0.26× | ||
| Q3 25 | 0.41× | — | ||
| Q2 25 | -17.92× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -2.30× | — | ||
| Q1 24 | -0.20× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
